188 related articles for article (PubMed ID: 32357955)
21. Tumor DNA as a Cancer Biomarker through the Lens of Colorectal Neoplasia.
Cohen JD; Diergaarde B; Papadopoulos N; Kinzler KW; Schoen RE
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2441-2453. PubMed ID: 33033144
[TBL] [Abstract][Full Text] [Related]
22. Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review.
Liss MA; Leach RJ; Sanda MG; Semmes OJ
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2454-2462. PubMed ID: 33093161
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers and Strategies for Early Detection of Ovarian Cancer.
Bast RC; Lu Z; Han CY; Lu KH; Anderson KS; Drescher CW; Skates SJ
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2504-2512. PubMed ID: 33051337
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive Diagnostics for Early Detection of Lung Cancer: Challenges and Potential with a Focus on Changes in DNA Methylation.
Farooq M; Herman JG
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2416-2422. PubMed ID: 33148791
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers for early detection of liver cancer: focus on clinical evaluation.
Sun S; Day PJ; Lee NP; Luk JM
Protein Pept Lett; 2009; 16(5):473-8. PubMed ID: 19442225
[TBL] [Abstract][Full Text] [Related]
26. Development of common data elements: the experience of and recommendations from the early detection research network.
Winget MD; Baron JA; Spitz MR; Brenner DE; Warzel D; Kincaid H; Thornquist M; Feng Z
Int J Med Inform; 2003 Apr; 70(1):41-8. PubMed ID: 12706181
[TBL] [Abstract][Full Text] [Related]
27. Prevalidation of salivary biomarkers for oral cancer detection.
Elashoff D; Zhou H; Reiss J; Wang J; Xiao H; Henson B; Hu S; Arellano M; Sinha U; Le A; Messadi D; Wang M; Nabili V; Lingen M; Morris D; Randolph T; Feng Z; Akin D; Kastratovic DA; Chia D; Abemayor E; Wong DT
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):664-72. PubMed ID: 22301830
[TBL] [Abstract][Full Text] [Related]
28. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
29. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.
Schully SD; Carrick DM; Mechanic LE; Srivastava S; Anderson GL; Baron JA; Berg CD; Cullen J; Diamandis EP; Doria-Rose VP; Goddard KA; Hankinson SE; Kushi LH; Larson EB; McShane LM; Schilsky RL; Shak S; Skates SJ; Urban N; Kramer BS; Khoury MJ; Ransohoff DF
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25688116
[TBL] [Abstract][Full Text] [Related]
30. Cancer Proteomics and the Elusive Diagnostic Biomarkers.
Bradshaw RA; Hondermarck H; Rodriguez H
Proteomics; 2019 Nov; 19(21-22):e1800445. PubMed ID: 31172665
[TBL] [Abstract][Full Text] [Related]
31. Design and utilization of the colorectal and pancreatic neoplasm virtual biorepository: An early detection research network initiative.
Amin W; Singh H; Dzubinski LA; Schoen RE; Parwani AV
J Pathol Inform; 2010 Oct; 1():22. PubMed ID: 21031013
[TBL] [Abstract][Full Text] [Related]
32. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
Srivastava A; Creek DJ
Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
[TBL] [Abstract][Full Text] [Related]
33. The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.
Grizzle WE; Semmes OJ; Basler J; Izbicka E; Feng Z; Kagan J; Adam BL; Troyer D; Srivastava S; Thornquist M; Zhang Z; Thompson IM
Urol Oncol; 2004; 22(4):337-43. PubMed ID: 15283893
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers in pharmacology and drug discovery.
Anderson DC; Kodukula K
Biochem Pharmacol; 2014 Jan; 87(1):172-88. PubMed ID: 24001556
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics.
Dragani TA; Matarese V; Colombo F
Bioessays; 2020 Apr; 42(4):e1900122. PubMed ID: 32128843
[TBL] [Abstract][Full Text] [Related]
36. Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.
Young MR; Wagner PD; Ghosh S; Rinaudo JA; Baker SG; Zaret KS; Goggins M; Srivastava S
Pancreas; 2018 Feb; 47(2):135-141. PubMed ID: 29346214
[TBL] [Abstract][Full Text] [Related]
37. The Potential of Circular RNAs as Cancer Biomarkers.
Brown JR; Chinnaiyan AM
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2541-2555. PubMed ID: 33060073
[TBL] [Abstract][Full Text] [Related]
38. Early detection research program at the NCI.
Srivastava S; Rossi SC
Int J Cancer; 1996 Feb; 69(1):35-7. PubMed ID: 8600056
[TBL] [Abstract][Full Text] [Related]
39. A favorable view: progress in cancer prevention and screening.
Greenwald P
Recent Results Cancer Res; 2007; 174():3-17. PubMed ID: 17302181
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
